SS Innovations International (SSII) Shareholder's Equity (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.66% |
| Dec 31, 2025 | -3.61% |
| Sep 30, 2025 | -5.65% |
| Jun 30, 2025 | 3.62% |
| Mar 31, 2025 | 201.36% |
| Dec 31, 2024 | -1.70% |
| Sep 30, 2024 | -7.33% |
| Jun 30, 2024 | -11.80% |
| Mar 31, 2024 | -15.06% |
| Dec 31, 2023 | 20.47% |
| Sep 30, 2023 | 1,366.56% |
| Jun 30, 2023 | 127.65% |
| Mar 31, 2023 | -50.67% |
| Dec 31, 2022 | -61.76% |
| Sep 30, 2022 | -44.58% |
| Jun 30, 2022 | -203.75% |
| Mar 31, 2022 | -164.39% |
| Dec 31, 2021 | 162.20% |
| Sep 30, 2021 | -9.74% |
| Jun 30, 2021 | -12.96% |
| Mar 31, 2021 | 12.61% |
| Dec 31, 2020 | 34.21% |
| Sep 30, 2020 | -9.61% |
| Jun 30, 2020 | -10.43% |
| Mar 31, 2020 | -2.64% |
| Dec 31, 2019 | 39.86% |
| Sep 30, 2019 | -162.34% |
| Jun 30, 2019 | -74.17% |
| Mar 31, 2019 | -73.47% |
| Dec 31, 2018 | 15.58% |
| Sep 30, 2018 | -687.76% |
| Jun 30, 2018 | -120.34% |
| Mar 31, 2018 | 63.14% |
| Dec 31, 2017 | -73.43% |
| Sep 30, 2017 | 183.97% |